WebAuron Therapeutics 1,241 من المتابعين على LinkedIn. Illuminating the path to cure cancer Auron Therapeutics aims to cure cancer by radically changing the paradigm of cancer therapeutics from cell killing to transformation of malignant cells into more normal functioning cells. This transformation, called differentiation therapy, reactivates endogenous cellular programs … WebInvestor search results. When you upgrade to Crunchbase Pro, you can access all search results, save to custom lists or to Salesforce, and get notified when new companies, people, or deals meet your search criteria.
Jason Pontin - Partner @ DCVC - Crunchbase Person Profile
WebCH4 Global has 6 investors including DCVC and DCVC Bio. How much funding has CH4 Global raised to date? CH4 Global has raised $16M. When was the last funding round for CH4 Global? CH4 Global closed its last funding round on Oct 6, 2024 from a Series A round. Who are CH4 Global 's competitors? WebArmed with some data from our friends at CrunchBase, I broke down the largest US startup funding rounds from March No Result . View All Result ... Amogy has now raised a total of $208.3M in total equity funding and is backed by Yanmar Ventures, Amazon, DCVC, Temasek Holdings, and Newlab.Investors in the round: AP Ventures, Aramco Ventures, … josh carefoot
Alan Cohen - Partner @ DCVC - Crunchbase Person Profile
WebAnna Fokina is an Investment Director at DCVC Bio. Prior to DCVC Bio, Anna worked at Monsanto Growth Ventures (MGV), the Venture Capital arm of Monsanto, which was one of the most active investors globally in agriculture. In addition, Anna brings experience from the financial markets, including past roles as a long-short equity analyst and an WebDCVC has made 476 investments. Their most recent investment was on Mar 22, 2024, when Amogy raised $139.2M. DCVC has made 89 diversity investments. Their most recent diversity investment was on Nov 29, 2024, when Medical Informatics raised $17M. DCVC has had 100 exits. DCVC 's most notable exits include Uber, Rocket Lab, and Elastic. WebKelly Chen is a Partner at DCVC. Kelly’s interest has always been how to use data and optimization to push boundaries, faster. From her career running a fixed income trading desk to building out a new quant product line for a global investment bank, she has focused closely on building the best models, structuring, and sales teams to optimize. josh carey facebook